Back to top

BioMarin announces FDA accepts sNDA for full approval of Voxzogo

BioMarin (BMRN) Pharmaceutical announced that the U.S. FDA has accepted the company’s supplemental New Drug Application for Voxzogo for full approv...

Read full article here »

In-Depth Zacks Research for the Tickers Above

Normally $25 each - click below to receive one report FREE:

BioMarin Pharmaceutical Inc. (BMRN)